Major microbiota dysbiosis in severe obesity: Fate after bariatric surgery

Gut

Volumn 68, Issue 1, 2019, Pages 70-82

  Aron Wisnewsky, Judith ^a,b   Prifti, Edi ^a,c   Belda, Eugeni ^a,c   Ichou, Farid ^d   Kayser, Brandon D ^a   Dao, Maria Carlota ^a   Verger, Eric O ^a   Hedjazi, Lyamine ^d   Bouillot, Jean Luc ^e   Chevallier, Jean Marc ^f   Pons, Nicolas ^g   Le Chatelier, Emmanuelle ^g   Levenez, Florence ^g   Ehrlich, Stanislav Dusko ^g   Dore, Joel ^g   Zucker, Jean Daniel ^a,c   Clément, Karine ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c ICAN   (France)

^d Institute of Cardiometabolism and Nutrition ICAN   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUTARIC ACID; GLYCINE; HISTIDINE; HOMOVANILLIC ACID; INTERLEUKIN 6; METHYLMALONIC ACID; BIOLOGICAL MARKER;

ABDOMINAL OBESITY; ADULT; ARTICLE; BACTERIUM; BACTEROIDES VULGATUS; BARIATRIC SURGERY; BODY COMPOSITION; BODY MASS; BODY WEIGHT LOSS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; COPROCOCCUS; DETERIORATION; DISEASE ASSOCIATION; DYSBIOSIS; ERYSIPELATOCLOSTRIDIUM RAMOSUM; EUBACTERIUM; FAECALIBACTERIUM; FAT FREE MASS; FAT MASS; FEMALE; FIRMICUTES; GASTRIC BANDING; GASTRIC BYPASS SURGERY; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERTENSION; INTESTINE FLORA; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METABOLOME; METABOLOMICS; METAGENOMICS; MICROBIAL GENE; MICROBIAL GENE RICHNESS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; ROUX-EN-Y GASTRIC BYPASS; RUMINOCOCCACEAE; SPECIES COMPOSITION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROBIOLOGY; MORBID OBESITY; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; BARIATRIC SURGERY; BIOMARKERS; CHROMATOGRAPHY, LIQUID; COMORBIDITY; DYSBIOSIS; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; MASS SPECTROMETRY; METAGENOMICS; OBESITY, MORBID; PHENOTYPE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 85048623694     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2018-316103     Document Type: Article

References (60)

1. Kopelman PG. Obesity as a medical problem. Nature 2000;404:635-43.
2. C ani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57:1470-81.
3. Dao MC, Clément K. Gut microbiota and obesity: Concepts relevant to clinical care. Eur J Intern Med 2018;48.
4. L e Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013;500:541-6.
5. C otillard A, Kennedy SP, Kong LC, et al. Dietary intervention impact on gut microbial gene richness. Nature 2013;500:585-8.
6. Blüher M. Are metabolically healthy obese individuals really healthy? Eur J Endocrinol Eur Fed Endocr Soc 2014;171:R209-19.
7. A ngrisani L, Santonicola A, Iovino P, et al. Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014. Obes Surg 2017;27:2279-89.
8. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012;307:56-65.
9. A ron-Wisnewsky J, Doré J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol 2012;9:590-8.
10. Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med 2016;8:67.
11. T remaroli V, Karlsson F, Werling M, et al. Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation. Cell Metab 2015;22:228-38.
12. L iu R, Hong J, Xu X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med 2017;23:859-68.
13. Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and low-grade inflammation markers. Diabetes 2010;59:3049-57.
14. A ron-Wisnewsky J, Verger EO, Bounaix C, et al. Nutritional and Protein Deficiencies in the Short Term following Both Gastric Bypass and Gastric Banding. PLoS One 2016;11:e0149588.
15. Kayser BD, Lhomme M, Dao MC, et al. Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss. Int J Obes 2017;41.
16. Verger EO, Aron-Wisnewsky J, Dao MC, et al. Micronutrient and Protein Deficiencies After Gastric Bypass and Sleeve Gastrectomy: A 1-year Follow-up. Obes Surg 2016;26:785-96.
17. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301.
18. T homas V, Clark J, Doré J. Fecal microbiota analysis: An overview of sample collection methods and sequencing strategies. Future Microbiol 2015;10:1485-504.
19. Suau A, Bonnet R, Sutren M, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999;65:4799-807.
20. G odon JJ, Zumstein E, Dabert P, et al. Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol 1997;63:2802-13.
21. N ielsen HB, Almeida M, Juncker AS, et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat Biotechnol 2014;32:822-8.
22. Boudah S, Olivier MF, Aros-Calt S, et al. Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2014;966:34-47.
23. I nzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: A patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2015;58:429-42.
24. Holmes I, Harris K, Quince C. Dirichlet multinomial mixtures: Generative models for microbial metagenomics. PLoS One 2012;7:e30126.
25. Vandeputte D, Kathagen G, D'hoe K, D'hoe K, et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature 2017;551:507-11.
26. R evelles O, Espinosa-Urgel M, Fuhrer T, et al. Multiple and interconnected pathways for L-lysine catabolism in Pseudomonas putida KT2440. J Bacteriol 2005;187:7500-10.
27. Perfetti R, Campbell RJ, Titus J, et al. Catabolism of pipecolate to glutamate in Pseudomonas putida. J Biol Chem 1972;247:4089-95.
28. Puzziferri N, Roshek TB, Mayo HG, et al. Long-term follow-up after bariatric surgery: A systematic review. JAMA 2014;312:934-42.
29. A hima RS, Lazar MA, Physiology LMA. Physiology. The health risk of obesity-better metrics imperative. Science 2013;341:856-8.
30. Dao MC, Everard A, Aron-Wisnewsky J, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology. Gut 2016;65:426-36.
31. Wu H, Esteve E, Tremaroli V, et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med 2017;23:850-8.
32. Forslund K, Hildebrand F, Nielsen T, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 2015;528:262-6.
33. Falony G, Joossens M, Vieira-Silva S, et al. Population-level analysis of gut microbiome variation. Science 2016;352:560-4.
34. N guyen NQ, Debreceni TL, Burgess JE, et al. Impact of gastric emptying and small intestinal transit on blood glucose, intestinal hormones, glucose absorption in the morbidly obese. Int J Obes 2018 (accessed 30 Jan 2018). 35 C arswell KA, Vincent RP, Belgaumkar AP, et al. The effect of bariatric surgery on intestinal absorption and transit time. Obes Surg 2014;24:796-805.
35. A dam B, Koldehoff M, Ditschkowski M, et al. Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease. Dig Dis Sci 2016;61:2019-26.
36. Monteiro-Sepulveda M, Touch S, Mendes-Sá C, et al. Jejunal T Cell Inflammation in Human Obesity Correlates with Decreased Enterocyte Insulin Signaling. Cell Metab 2015;22:113-24.
37. Vandeputte D, Falony G, Vieira-Silva S, et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 2016;65:57-62.
38. Pedersen HK, Gudmundsdottir V, Nielsen HB, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 2016;535:376-81.
39. Dewulf EM, Cani PD, Claus SP, et al. Insight into the prebiotic concept: Lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2013;62:1112-21.
40. R ath HC, Wilson KH, Sartor RB. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun 1999;67:2969-74.
41. Dicksved J, Halfvarson J, Rosenquist M, et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. Isme J 2008;2:716-27.
42. G ersemann M, Becker S, Nuding S, et al. Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD. J Crohns Colitis 2012;6:425-34.
43. Di Luccia B, Crescenzo R, Mazzoli A, et al. Rescue of Fructose-Induced Metabolic Syndrome by Antibiotics or Faecal Transplantation in a Rat Model of Obesity. PLoS One 2015;10:e0134893.
44. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an antiinflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008;105:16731-6.
45. G ao K, Xu A, Krul C, et al. Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3,4-dihydroxyphenylacetic acid has antiproliferative activity. J Nutr 2006;136:52-7.
46. G ralka E, Luchinat C, Tenori L, et al. Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner. Am J Clin Nutr 2015;102:1313-22.
47. A ggarwal S, Ahuja V, Paul J. Attenuated GABAergic signaling in intestinal epithelium contributes to pathogenesis of ulcerative colitis. Dig Dis Sci 2017;62:2768-79.
48. Vital M, Howe AC , Tiedje JM. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. MBio 2014;5:e00889.
49. Kong LC, Tap J, Aron-Wisnewsky J, et al. Gut microbiota after gastric bypass in human obesity: Increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr 2013;98:16-24.
50. Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 2009;106:2365-70.
51. L iou AP, Paziuk M, Luevano JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013 5:178ra41.
52. R yan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014;509:183-8.
53. G raessler J, Qin Y, Zhong H, et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: Correlation with inflammatory and metabolic parameters. Pharmacogenomics J 2013;13:514-22.
54. R andazzo A, Kornreich A, Lissoir B. A Clostridium hathewayi isolate in blood culture of a patient with an acute appendicitis. Anaerobe 2015;35:44-7.
55. Zhang Q, Wu Y, Wang J, et al. Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium. Sci Rep 2016;6:27572.
56. N arath SH, Mautner SI, Svehlikova E, et al. An untargeted metabolomics approach to characterize short-term and long-term metabolic changes after bariatric surgery. PLoS One 2016;11:e0161425.
57. N ewgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009;9:311-26.
58. Floegel A, Stefan N, Yu Z, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 2013;62:639-48.
59. R othschild D, Weissbrod O, Barkan E, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 2018;555:210-5.
60. Kootte RS, Levin E, Salojärvi J, et al. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. Cell Metab 2017;26:611-9.